as on
| Source : NSE
as on August 20, 2025 at 4:01 PM IST
Day's Low
Day's High
0.40%
Downside
0.94%
Upside
52 Week's Low
52 Week's High
33.72%
Downside
35.96%
Upside
Market Stats | |
Previous Close | ₹176.20 |
Open | ₹176.82 |
Volume | 2.61L |
Upper Circuit | ₹211.44 |
Lower Circuit | ₹140.96 |
Day's Low | ₹176.33 |
Day's High | ₹178.7 |
52 Week Low | ₹117.35 |
52 Week High | ₹240.7 |
Returns % | |
1 Month Return | -6.13 % |
3 Month Return | + 4.02 % |
1 Year Return | + 7.73 % |
3 Year Return | + 50.6 % |
5 Year Return | + 34.61 % |
Check Sequent market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹4,410.90 Cr
Return on Equity (ROE)
1.42
PE Ratio (TTM)
148.07
Return on capital employed (ROCE)
2.23
Industry PE ratio
43.53
Beta (LTM)
1.51
P/B Ratio
2.87
Dividend Yield
0PEG Ratio
151.09
Quarterly Earnings Growth YOY
93.93
EPS (TTM)
1.29
Sector
Pharmaceuticals
Book Value
28.15
Technical Analysis
Bullish
View Technical Analysis
Track how Sequent P/E has moved over time to understand its valuation trends.
Sequent in the last 5 years
Lowest (-117.80x)
January 17, 2023
Industry (43.53x)
August 19, 2025
Today (148.07x)
August 19, 2025
Highest (1034.67x)
September 27, 2024
Today’s Price to Earnings Ratio: 148.07x
Get share price movements and forecasts by analysts on Sequent.
Excluding Excise Duty and Other Income, represents Net Revenue
Sequent revenue growth forecast
Expected growth rate , :0
Forecast
Actual
Including amortisation and stock based compensations
Sequent EPS growth forecast
EPS estimate , :0
Forecast
Actual
Source: S&P Global Market Intelligence
Get the annual and quarterly financial summary of Sequent Scientific Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Sequent.
Sequent Scientific Ltd’s net profit jumped 119.82% since last year same period to ₹14.31Cr in the Q1 2025-2026. On a quarterly growth basis, Sequent Scientific Ltd has generated 53.54% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2021, Sequent Scientific Ltd has declared dividend of ₹0.50 per share on 30 Jun 2021 - translating a dividend yield of 0.28%.
Read More about DividendsCheck stock indices that include Sequent.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Sequent.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 52.61% | 0.00 | |
Foreign Institutions | 6.15% | 1.64 | |
Mutual Funds | 10.08% | ||
Retail Investors | 28.1% | ||
Others | 3.07% | 11.02 |
Compare market cap, revenue, PE, and other key metrics of Sequent with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 4,410.90 | 6.92% | 0.72 | 32 | 1,551 | |
BUY | 8,013.96 | 10.61% | 0.72 | 3,597 | 4,565 | |
NA | 45.19 | -16.85% | 0.00 | -22 | 104 | |
NA | 714.35 | 63.1% | 0.58 | 13 | 154 | |
NA | 46.99 | 19.79% | 0.50 | 1 | 67 |
Latest news and events in one place to help you make informed investing decisions in Sequent.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, SEQUENT stock has moved up by 2.7%
FII Holding Up
Foreign Institutions have increased holdings from 6.05% to 6.15% in Jun 2025 quarter
Revenue Rich
Revenue is up for the last 4 quarters, 373.16 Cr → 445.29 Cr (in ₹), with an average increase of 5.7% per quarter
Profit Spike
Netprofit is up for the last 4 quarters, 2.61 Cr → 14.31 Cr (in ₹), with an average increase of 40.7% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 52.61% of holdings in Jun 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 139.2% return, outperforming this stock by 88.6%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 28.7% return, outperforming this stock by 21.0%
Retail Holding Down
Retail Investor have decreased holdings from 28.36% to 28.10% in Jun 2025 quarter
MF Holding Down
Mutual Funds have decreased holdings from 10.22% to 10.08% in Jun 2025 quarter
Organisation | Sequent Scientific Ltd |
Headquarters | Bangalore |
Industry | Pharmaceuticals |
CEO | Kamal K Sharma |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Sequent.
Sequent share price today stands at ₹177.04, Open: ₹176.82, Previous Close: ₹176.2, High: ₹178.7, Low: ₹176.33, 52 Week High: ₹240.7, 52 Week Low: ₹117.35 as on .
To buy Sequent shares, you need to follow these steps:
Today's traded volume of Sequent is 2.61L. Which means that 2.61L shares of Sequent were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Sequent is ₹4,410.90 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Sequent’s 52 week high is ₹240.7 and 52 week low is ₹117.35. The current share price of Sequent is ₹177.04, which is -26.45% down from its 52 week high and 50.86% up from its 52 week low.